Danilo DAlessandro's most recent trade in ClearPoint Neuro Inc was a trade of 407 Common Stock done at an average price of $9.6 . Disclosure was reported to the exchange on Dec. 31, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 9.57 per share. | 31 Dec 2025 | 407 | 70,330 (0%) | 0% | 9.6 | 3,895 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 3,555 | 12,082 | - | - | Stock Options (right to buy) | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.10 per share. | 21 Nov 2025 | 3,555 | 69,923 (0%) | 0% | 8.1 | 28,796 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 10.15 per share. | 30 Jun 2025 | 376 | 66,368 (0%) | 0% | 10.1 | 3,816 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.29 per share. | 10 Jun 2025 | 4,754 | 65,992 (0%) | 0% | 13.3 | 63,181 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2025 | 16,313 | 65,253 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2025 | 16,313 | 79,030 (0%) | 0% | - | Common Stock | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.18 per share. | 12 Mar 2025 | 8,284 | 70,746 (0%) | 0% | 13.2 | 109,183 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2025 | 4,146 | 4,145 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2025 | 4,146 | 64,823 (0%) | 0% | - | Common Stock | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.70 per share. | 11 Mar 2025 | 2,106 | 62,717 (0%) | 0% | 12.7 | 26,746 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 18,765 | 18,765 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 18,765 | 70,206 (0%) | 0% | - | Common Stock | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.19 per share. | 06 Mar 2025 | 9,529 | 60,677 (0%) | 0% | 13.2 | 125,688 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 51,660 | 51,660 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 4.53 per share. | 31 Dec 2024 | 1,949 | 51,441 (0%) | 0% | 4.5 | 8,829 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.26 per share. | 20 Aug 2024 | 1,191 | 49,492 (0%) | 0% | 11.3 | 13,411 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 4.58 per share. | 28 Jun 2024 | 1,913 | 50,683 (0%) | 0% | 4.6 | 8,762 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.74 per share. | 10 Jun 2024 | 4,824 | 48,770 (0%) | 0% | 5.7 | 27,690 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2024 | 81,566 | 81,566 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 8,291 | 8,291 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2024 | 9,383 | 37,530 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2024 | 9,383 | 58,312 (0%) | 0% | 0 | Common Stock | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.24 per share. | 06 Mar 2024 | 4,718 | 53,594 (0%) | 0% | 6.2 | 29,440 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 5.77 per share. | 29 Dec 2023 | 1,479 | 48,929 (0%) | 0% | 5.8 | 8,534 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.34 per share. | 20 Aug 2023 | 1,166 | 52,408 (0%) | 0% | 5.3 | 6,226 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 6.15 per share. | 30 Jun 2023 | 1,371 | 53,574 (0%) | 0% | 6.2 | 8,432 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.91 per share. | 10 Jun 2023 | 2,526 | 52,203 (0%) | 0% | 6.9 | 17,455 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 46,913 | 46,913 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 15,637 | 15,637 | - | - | Stock Options (right to buy) | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Other type of transaction at price $ 7.20 per share. | 31 Dec 2022 | 1,252 | 54,729 (0%) | 0% | 7.2 | 9,014 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.23 per share. | 29 Sep 2022 | 4,958 | 53,477 (0%) | 0% | 10.2 | 50,720 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.24 per share. | 20 Aug 2022 | 583 | 58,435 (0%) | 0% | 13.2 | 7,719 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 23,400 | 58,214 (0%) | 0% | 0 | Common Stock | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 15,600 | 15,600 | - | - | Stock Options (right to buy) | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.22 per share. | 29 Sep 2021 | 4,958 | 33,465 (0%) | 0% | 17.2 | 85,377 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2021 | 11,750 | 11,750 | - | - | Stock Options (right to buy) | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2021 | 5,875 | 38,423 (0%) | 0% | 0 | Common Stock |